|
Quotes & Info
|
| AXN > SEC Filings for AXN > Form 8-K on 5-Jul-2012 | All Recent SEC Filings |
5-Jul-2012
Change in Directors or Principal Officers
On July 1, 2012 Bob Yunjun Ai resigned from his position as the Registrant's Chief Financial Officer.
On July 3, 2012, the Board of Directors for Aoxing Pharmaceutical Company appointed Guoan Zhang to serve as Interim Chief Financial Officer. Mr. Zhang has served as the Company's Senior Vice President of Finance since June 2010. From November 1, 2010 through February 1, 2011, Guoan Zhang also served as interim Chief Financial Officer of the Company.
The Board of Directors has also appointed Guirong Zhou to serve as Vice President for Research and Development. Ms. Zhou has over thirty years experience in pharmaceutical research and development.
|
|